FEUPX
Price
$51.85
Change
+$2.46 (+4.98%)
Updated
Apr 9 closing price
Net Assets
110.84B
SCIIX
Price
$6.59
Change
+$0.45 (+7.33%)
Updated
Apr 9 closing price
Net Assets
299.02M
Ad is loading...

FEUPX vs SCIIX

Header iconFEUPX vs SCIIX Comparison
Open Charts FEUPX vs SCIIXBanner chart's image
American Funds Europacific Growth F3
Price$51.85
Change+$2.46 (+4.98%)
VolumeN/A
Net Assets110.84B
Virtus SGA International Growth A
Price$6.59
Change+$0.45 (+7.33%)
VolumeN/A
Net Assets299.02M
FEUPX vs SCIIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FEUPX vs. SCIIX commentary
Apr 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEUPX is a Hold and SCIIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FEUPX has more cash in the bank: 111B vs. SCIIX (299M). FEUPX pays higher dividends than SCIIX: FEUPX (1.49) vs SCIIX (0.01). FEUPX was incepted earlier than SCIIX: FEUPX (8 years) vs SCIIX (29 years). SCIIX (1.57) is less costly to investors than FEUPX (0.47). FEUPX is a more actively managed with annual turnover of: 30.00 vs. SCIIX (10.00). SCIIX has a lower initial minimum investment than FEUPX: SCIIX (2500) vs FEUPX (1000000). FEUPX annual gain was more profitable for investors over the last year : -14.85 vs. SCIIX (-32.45). FEUPX return over 5 years is better than : 15.57 vs. SCIIX (-32.52).
FEUPXSCIIXFEUPX / SCIIX
Total Expense Ratio0.471.3036%
Annual Report Gross Expense Ratio0.471.5730%
Fund Existence8 years29 years-
Gain YTD-8.163-7.946103%
Front LoadN/A6%-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets111B299M37,124%
Annual Yield % from dividends1.490.0117,938%
Returns for 1 year-14.85-32.4546%
Returns for 3 years-8.74-35.2325%
Returns for 5 years15.57-32.52-48%
Returns for 10 yearsN/A-41.71-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TNVRX14.06N/A
N/A
1290 GAMCO Small/Mid Cap Value R
LHCVX16.79N/A
N/A
Lord Abbett Health Care R6
MMZOX15.18N/A
N/A
MassMutual Equity Opports Y
FDECX17.59N/A
N/A
Fidelity Advisor Capital Development C
TQMIX14.68N/A
N/A
AMG TimesSquare Mid Cap Growth I